1
|
Hou Y, Shang C, Meng T, Lou W. Anticancer potential of cardiac glycosides and steroid-azole hybrids. Steroids 2021; 171:108852. [PMID: 33887267 DOI: 10.1016/j.steroids.2021.108852] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/12/2020] [Revised: 04/03/2021] [Accepted: 04/12/2021] [Indexed: 01/03/2023]
Abstract
Steriods are well-known scaffolds that have a widespread occurrence in different compounds characterized by extensive biological properties including anticancer activity. Structural modifications on steroids always generate potential lead compounds with superior bioactivity, and creation of steroid hybrids by combining steroid with other anticancer pharmacophores in one molecule, which can exert the anticancer activity through different mechanisms, is one of the most promising strategies to enhance efficiency, overcome drug resistance and reduce side effects. Sugars and azoles, can act on diverse receptors, proteins and enzymes in cancer cells, are pharmacologically significant scaffolds in the development of novel anticancer agents. Therefore, steroid-sugar hybrids cardiac glycosides and steroid-azole hybrids are privileged scaffolds for the discovery of novel anticancer candidates. This review emphasized on the development, the structure-activity relationship and the mechanism of action of cardiac glycosides and steroid-azole hybrids with potential application for fighting against various cancers including drug-resistant forms to facilitate further rational design of novel drug candidates covering articles published between 2015 and 2020.
Collapse
Affiliation(s)
- Yani Hou
- School of Medicine, Xi'an Peihua University, Xi'an 710125, Shannxi, China
| | - Congshan Shang
- School of Medicine, Xi'an Peihua University, Xi'an 710125, Shannxi, China
| | - Tingting Meng
- School of Medicine, Xi'an Peihua University, Xi'an 710125, Shannxi, China
| | - Wei Lou
- Department of Respiratory, Zhuji Affiliated Hospital of Shaoxing University, Zhuji, China.
| |
Collapse
|
2
|
Wen X, Zhou Y, Zeng J, Liu X. Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents. Curr Top Med Chem 2020; 20:1441-1460. [DOI: 10.2174/1568026620666200128143230] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2019] [Revised: 12/15/2019] [Accepted: 12/25/2019] [Indexed: 12/16/2022]
Abstract
1,2,4-Triazole derivatives possess promising in vitro and in vivo anticancer activity, and many
anticancer agents such as fluconazole, tebuconazole, triadimefon, and ribavirin bear a 1,2,4-triazole
moiety, revealing their potential in the development of novel anticancer agents. This review emphasizes
the recent advances in 1,2,4-triazole-containing compounds with anticancer potential, and the structureactivity
relationships as well as mechanisms of action are also discussed.
Collapse
Affiliation(s)
- Xiaoyue Wen
- The Institute of Infection and Inflammation, China Three Gorges University, Yichang, Hubei 443000, China
| | - Yongqin Zhou
- The Institute of Infection and Inflammation, China Three Gorges University, Yichang, Hubei 443000, China
| | - Junhao Zeng
- The Institute of Infection and Inflammation, China Three Gorges University, Yichang, Hubei 443000, China
| | - Xinyue Liu
- The Institute of Infection and Inflammation, China Three Gorges University, Yichang, Hubei 443000, China
| |
Collapse
|
3
|
Sethi A, Singh RP, Pathak R, Shukla D, Amandeep, Yadav P. One pot synthesis of novel pregnane-sulphur prodrugs, spectroscopic investigation, conformational analysis, chemical reactivity, Fukui function and their mathematical model. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2019.127136] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
4
|
Katagiri K, Kodera H, Tayu M, Saito N. Facile Construction of an α-(1-Cyclopentenyl)ketone Core by Ruthenium-catalyzed Hydrative Cyclization of 1,6-Allenyne: Total Synthesis of (+)-Myomontanone. CHEM LETT 2019. [DOI: 10.1246/cl.190202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
- Koichi Katagiri
- Meiji Pharmaceutical University, Kiyose, Tokyo 204-8588, Japan
| | - Haruka Kodera
- Meiji Pharmaceutical University, Kiyose, Tokyo 204-8588, Japan
| | - Masanori Tayu
- Meiji Pharmaceutical University, Kiyose, Tokyo 204-8588, Japan
| | - Nozomi Saito
- Meiji Pharmaceutical University, Kiyose, Tokyo 204-8588, Japan
| |
Collapse
|
5
|
Song P, Cui F, Li N, Xin J, Ma Q, Meng X, Wang C, Cao Q, Gu Y, Ke Y, Zhang Q, Liu H. Synthesis, Cytotoxic Activity Evaluation of Novel 1,2,3-Triazole Linked Quinazoline Derivatives. CHINESE J CHEM 2017. [DOI: 10.1002/cjoc.201700005] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Panpan Song
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Fei Cui
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Na Li
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Jingchao Xin
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Qisheng Ma
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Xiangchuan Meng
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Chaojie Wang
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Qinpo Cao
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Yifei Gu
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Yu Ke
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Qiurong Zhang
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Hongmin Liu
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| |
Collapse
|
6
|
Silva-Ortiz AV, Bratoeff E, Ramírez-Apan T, Heuze Y, Soriano J, Moreno I, Bravo M, Bautista L, Cabeza M. Synthesis of new derivatives of 21-imidazolyl-16-dehydropregnenolone as inhibitors of 5α-reductase 2 and with cytotoxic activity in cancer cells. Bioorg Med Chem 2017; 25:1600-1607. [DOI: 10.1016/j.bmc.2017.01.018] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2016] [Revised: 01/10/2017] [Accepted: 01/13/2017] [Indexed: 12/31/2022]
|
7
|
Silva-Ortiz AV, Bratoeff E, Ramírez-Apan MT, García-Becerra R, Ordaz-Rosado D, Noyola-Martínez N, Castillo-Bocanegra R, Barrera D. Synthesis and biological activity of two pregnane derivatives with a triazole or imidazole ring at C-21. J Steroid Biochem Mol Biol 2016; 159:8-18. [PMID: 26924581 DOI: 10.1016/j.jsbmb.2016.02.013] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/03/2015] [Revised: 01/22/2016] [Accepted: 02/11/2016] [Indexed: 10/22/2022]
Abstract
Pregnane derivatives are studied as agents for the treatment of different hormone-dependent diseases. The biological importance of these steroids is based on their potential use against cancer. In this study, we report the synthesis, characterization and biological activity of two pregnane derivatives with a triazole (3β-hydroxy-21-(1H-1,2,4-triazol-1-yl)pregna-5,16-dien-20-one; T-OH) or imidazole (3β-hydroxy-21-(1H-imidazol-1-yl)pregna-5,16-dien-20-one; I-OH) moieties at C-21. These derivatives were synthesized from 16-dehydropregnenolone acetate. The activity on cell proliferation of the compounds was measured on three human cancer cells lines: prostate cancer (PC-3), breast cancer (MCF7) and lung cancer (SK-LU-1). The cytotoxic and antiproliferative effects of T-OH and I-OH were assessed by using SBR and XTT methods, respectively. The gene expressions were evaluated by real time PCR. In addition, results were complemented by docking studies and transactivation assays using an expression vector to progesterone and androgen receptor. Results show that the two compounds inhibited the three cell lines proliferation in a dose-dependent manner. Compound I-OH downregulated the gene expression of the cyclins D1 and E1 in PC-3 and MFC7 cells; however, effect upon Ki-67, EAG1, BIM or survivin genes was not observed. Docking studies show poor interaction with the steroid receptors. Nevertheless, the transactivation assays show a weak antagonist effect of I-OH on progesterone receptor but not androgenic or antiandrogenic actions. In conclusion, the synthesized compounds inhibited cell proliferation as well as genes key to cell cycle of PC-3 and MCF7 cell lines. Therefore, these compounds could be considered a good starting point for the development of novel therapeutic alternatives to treat cancer.
Collapse
Affiliation(s)
- Aylin Viviana Silva-Ortiz
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico, D.F. 04510, Mexico
| | - Eugene Bratoeff
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico, D.F. 04510, Mexico
| | | | - Rocío García-Becerra
- Departamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Avenida Vasco de Quiroga No. 15, Col. Belisario Domínguez, Sección XVI, México, D.F. 14080, Mexico
| | - David Ordaz-Rosado
- Departamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Avenida Vasco de Quiroga No. 15, Col. Belisario Domínguez, Sección XVI, México, D.F. 14080, Mexico
| | - Nancy Noyola-Martínez
- Departamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Avenida Vasco de Quiroga No. 15, Col. Belisario Domínguez, Sección XVI, México, D.F. 14080, Mexico
| | - Rafael Castillo-Bocanegra
- Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Mexico, D.F. 04510, Mexico
| | - David Barrera
- Departamento de Biología de la Reproducción, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Avenida Vasco de Quiroga No. 15, Col. Belisario Domínguez, Sección XVI, México, D.F. 14080, Mexico.
| |
Collapse
|